Estrogen modulation of endothelial nitric oxide synthase

Endocrine Reviews

Volumn 23, Issue 5, 2002, Pages 665-686

  Chambliss, Ken L ^a   Shaul, Philip W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; ESTROGEN; ESTROGEN RECEPTOR; HEAT SHOCK PROTEIN 90; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR;

ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CAVEOLA; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ESTROGEN ACTIVITY; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HORMONAL REGULATION; HORMONE RECEPTOR INTERACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD VESSELS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; ESTROGENS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, ESTROGEN; VASCULAR DISEASES;

EID: 0036798936     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2001-0045     Document Type: Article

References (141)

1. Farhat MY, Lavigne MC, Ramwell PW 1996 The vascular protective effects of estrogen. FASEB J 10:615-624
2. Mendelsohn ME, Karas RH 1999 The protective effects of estrogen on the cardiovascular system. N Engl J Med 340:1801-1811
3. Moncada S, Higgs A 1993 The L-arginine-nitric oxide pathway. N Engl J Med 329:2002-2012
4. Mendelsohn ME, Karas RH 2001 The time has come to stop letting the HERS tale wag the dogma. Circulation 104:2256-2259
5. Barrett-Connor E, Bush TL 1991 Estrogen and coronary heart disease in women. JAMA 265:1867
6. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR 1992 Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016-1037
7. Stevenson JC, Crook D, Godsland IF, Collins P, Whitehead MI 1994 Hormone replacement therapy and the cardiovascular system. Nordipid effects. Drugs 47 (Suppl)2:35-41
8. Guetta V, Cannon ROI 1996 Cardiovascular effects of estrogen and lipid-lowering therapies in postmenopausal women. Circulation 93:1928-1937
9. Colditz GA, Willett WC, Stampfer MJ, Rosner B, Speizer FE, Hennekens CH 1987 Menopause and the risk of coronary heart disease in women. N Engl J Med 316:1105-1110
10. Belchetz PE 1994 Hormonal treatment of postmenopausal women. N Engl J Med 330:1062-1071
11. Mendelsohn ME, Karas RH 1994 Estrogen and the blood vessel wall. Curr Opin Cardiol 9:619-626
12. Bush TL, Barrett-Connor E, Cowan LD, Criqui MH, Wallace RB, Suchindran CM, Tyroler HA, Rifkind BM 1987 Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation 75:1102-1109
13. Gruchow H, Anderson AJ, Barboriak JJ, Sobocinski KA 1988 Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 115:954-963
14. Mendelsohn ME 2000 Mechanisms of estrogen action in the cardiovascular system. J Steroid Biochem Mol Biol 74:337-343
15. th ed. Philadelphia: Saunders; 110-133; 301-319; 751-784
16. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR 1997 Aromatase expression in health and disease. Recent Prog Horm Res 52:185-213
17. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye JC 1995 Estrogen synthesis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 136:1523-1529
18. Harada N, Sasano H, Murakami H, Ohkuma T, Nagura H, Takagi Y 1999 Localized expression of aromatase in human vascular tissues. Circ Res 84:1285-1291
19. Bryant HU, Dere WH 1998 Selective estrogen receptor modulators: an alternative to hormone replacement therapy. Proc Soc Exp Biol Med 217:45-52
20. Knight DC, Eden JA 1995 Phytoestrogens-a short review. Maturitas 22:167-175
21. Sorensen KE, Dorup I, Hermann AP, Mosekilde L 1998 Combined hormone replacement therapy does not protect women against the age-related decline in endothelium-dependent vasomotor function. Circulation 97:1234-1238
22. Majmudar NG, Robson SC, Ford GA 2000 Effects of the menopause, gender, and estrogen replacement therapy on vascular nitric oxide activity. J Clin Endocrinol Metab 85:1577-1583
23. Kawano H, Motoyama T, Kugiyama K, Hirashima O, Ohgushi M, Yoshimura M, Ogawa H, Okumura K, Yasue H 1996 Menstrual cyclic variation of endothelium-dependent vasodilation of the brachial artery: possible role of estrogen and nitric oxide. Proc Assoc Am Physicians 108:473-480
24. English JL, Jacobs LO, Green G, Andrews TC 1998 Effect of the menstrual cycle on endothelium-dependent vasodilation of the brachial artery in normal young women. Am J Cardiol 82:256-258
25. Chan NN, MacAllister RJ, Colhoun HM, Vallance P, Hingorani AD 2001 Changes in endothelium-dependent vasodilatation and α-adrenergic responses in resistance vessels during the menstrual cycle in healthy women. J Clin Endocrinol Metab 86:2499-2504
26. Pinto S, Virdis A, Ghiadoni L, Bernini G, Lombardo M, Petraglia F, Genazzani AR, Taddei S, Salvetti A 1997 Endogenous estrogen and acetylcholine-induced vasodilation in normotensive women. Hypertension 29:268-273
27. Rosselli M, Imthurm B, Macas E, Keller PJ, Dubey RK 1994 Circulating nitrite/nitrate levels increase with follicular development: indirect evidence for estradiol mediated NO release. Biochem Biophys Res Commun 202:1543-1552
28. Kharitonov SA, Logan-Sinclair RB, Busset CM, Shinebourne EA 1994 Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J 72:243-245
29. Herrington DM, Braden GA, Williams JK, Morgan TM 1994 Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy. Am J Cardiol 73:951-952
30. Lieberman EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC, Creager MA 1994 Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 121:936-941
31. Rosselli M, Imthurn B, Keller PJ, Jackson EK, Dubey RK 1995 Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate. A two-year follow-up study. Hypertension 25:848-853
32. Best PJ, Berger PB, Miller VM, Lerman A 1998 The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128:285-288
33. Saitta A, Altavilla D, Cucinotta D, Morabito N, Frisina N, Corrado F, D'Anna R, Lasco A, Squadrito G, Gaudio A, Cancellieri F, Arcoraci V, Squadrito F 2001 Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women. Arterioscler Thromb Vasc Biol 21:1512-1519
34. John S, Jacobi J, Schlaich MP, Delles C, Schmieder RE 2000 Effects of oral contraceptives on vascular endothelium in premenopausal women. Am J Obstet Gynecol 183:28-33
35. New G, Timmins KL, Duffy SJ, Tran BT, O'Brien RC, Harper RW, Meredith IT 1997 Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol 29:1437-1444
36. McCrohon JA, Walters WA, Robinson JT, McCredie RJ, Turner L, Adams MR, Handelsman DJ, Celermajer DS 1997 Arterial reactivity is enhanced in genetic males taking high dose estrogens. J Am Coll Cardiol 29:1432-1436
37. Reis SE, Gloth ST, Blumenthal RS, Resar JR, Zacur HA, Gerstenblith G, Brinker JA 1994 Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 89:52-60
38. Gilligan DM, Quyyumi AA, Cannon III RO 1994 Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 89:2545-2551
39. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon III RO 1994 Acute vascular effects of estrogen in postmenopausal women. Circulation 90:786-791
40. Guetta V, Quyyumi AA, Prasad A, Panza JA, Waclawiw M, Cannon III RO 1997 The role of nitric oxide in coronary vascular effects of estrogen in postmenopausal women. Circulation 96:2795-2801
41. Collins P, Rosano GM, Sarrel PM, Ulrich L, Adamopoulos S, Beale CM, McNeill JG, Poole-Wilson PA 1995 17β-Estradiol attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 92:24-30
42. Blumenthal RS, Heldman AW, Brinker JA, Resar JR, Coombs VJ, Gloth ST, Gerstenblith G, Reis SE 1997 Acute effects of conjugated estrogens on coronary blood flow response to acetylcholine in men. Am J Cardiol 80:1021-1024
43. Reis SE, Holubkov R, Zell KA, Smith AJ, Cohen HA, Feldman MD, Blumenthal RS 1998 Estrogen acutely abolishes abnormal cold-induced coronary constriction in men. Chest 114:1556-1561
44. Walker HA, Dean TS, Sanders TA, Jackson G, Ritter JM, Chowienczyk PJ 2001 The phytoestrogen genistein produces acute nitric oxide-dependent dilation of human forearm vasculature with similar potency to 17β-estradiol. Circulation 103:258-262
45. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, Rubanyi GM 1997 Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 96:3774-3777
46. Sudhir K, Chou TM, Messina LM, Hutchison SJ, Korach KS, Chatterjee K, Rubanyi GM 1997 Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet 349:1146-1147
47. Nechmad A, Merin G, Schwalb H, Shimon DV, Borman JB, Milgalter E, Mosseri M 1998 Estrogen induces nitric oxide-mediated vasodilation of human mammary arteries in vitro. Nitric Oxide 2:460-466
48. Sullivan Jr TR, Karas RH, Aronovitz M, Faller GT, Ziar JP, Smith JJ, O'Donnell Jr TF, Mendelsohn ME 1995 Estrogen inhibits the response-to-injury in a mouse carotid artery model. J Clin Invest 96:2482-2488
49. Chen SJ, Li H, Durand J, Oparil S, Chen YF 1996 Estrogen reduces myointimal proliferation after balloon injury of rat carotid artery. Circulation 93:577-584
50. Oparil S, Levine RL, Chen SJ, Durand J, Chen YF 1997 Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment. Circulahon 95:1301-1307
51. White CR, Darley-Usmar V, Oparil S 1997 No role for NO in estrogen-mediated vasoprotection? Circulation 96:2769-2771
52. Krasinski K, Spyridopoulos I, Asahara T, van der ZR, Isner JM, Losordo DW 1997 Estradiol accelerates functional endothelial recovery after arterial injury. Circulation 95:1768-1772
53. Tolbert T, Thompson JA, Bouchard P, Oparil S 2001 Estrogeninduced vasoprotection is independent of inducible nitric oxide synthase expression: evidence from the mouse carotid artery ligation model. Circulation 104:2740-2745
54. Morales DE, McGowan KA, Grant DS, Maheshwari S, Bhartiya D, Cid MC, Kleinman HK, Schnaper HW 1995 Estrogen promotes angiogenic activity in human umbilical vein endothelial cells in vitro and in a murine model. Circulation 91:755-763
55. Williams JK, Adams MR, Herrington DM, Clarkson TB 1992 Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 20:452-457
56. Williams JK, Adams MR, Klopfenstein HS 1990 Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 81:1680-1687
57. Keaney Jr JF, Shwaery GT, Xu A, Nicolosi RJ, Loscalzo J, Foxall TL, Vita JA 1994 17β-Estradiol preserves endothelial vasodilator function and limits low-density lipoprotein oxidation in hypercholesterolemic swine. Circulation 89:2251-2259
58. Sulistiyani, Adelman SJ, Chandrasekaran A, Jayo J, St Clair RW 1995 Effect of 17α-dihydroequilin sulfate, a conjugated equine estrogen, and ethynylestradiol on atherosclerosis in cholesterol-fed rabbits. Arterioscler Thromb Vasc Biol 15:837-846
59. Bourassa PA, Milos PM, Gaynor BJ, Breslow JL, Aiello RJ 1996 Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 93:10022-10027
60. Holm P, Andersen HO, Nordestgaard BG, Hansen BF, Kjeldsen K, Stender S 1995 Effect of oestrogen replacement therapy on development of experimental arteriosclerosis: a study in transplanted and balloon-injured rabbit aortas. Atherosclerosis 115:191-200
61. Holm P, Stender S, Andersen HO, Hansen BF, Nordestgaard BG 1997 Antiatherogenic effect of estrogen abolished by balloon catheter injury in cholesterol-clamped rabbits. Arterioscler Thromb Vasc Biol 17:1504-1511
62. Holm P, Korsgaard N, Shalmi M, Andersen HL, Hougaard P, Skouby SO, Stender S 1997 Significant reduction of the antiatherogenic effect of estrogen by long-term inhibition of nitric oxide synthesis in cholesterol-clamped rabbits. J Clin Invest 100:821-828
63. Holm P, Andersen HL, Andersen MR, Erhardtsen E, Stender S 1999 The direct antiatherogenic effect of estrogen is present, absent, or reversed, depending on the state of the arterial endothelium. A time course study in cholesterol-clamped rabbits. Circulation 100:1727-1733
64. Iafrati MD, Karas RH, Aronovitz M, Kim S, Sullivan Jr TR, Lubahn DB, O'Donnell Jr TF, Korach KS, Mendelsohn ME 1997 Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 3:545-548
65. Karas RH, Hodgin JB, Kwoun M, Krege JH, Aronovitz M, Mackey W, Gustafsson JA, Korach KS, Smithies O, Mendelsohn ME 1999 Estrogen inhibits the vascular injury response in estrogen receptor β-deficient female mice. Proc Natl Acad Sci USA 96:15133-15136
66. Karas RH, Schulten H, Pare G, Aronovitz MJ, Ohlsson C, Gustafsson JA, Mendelsohn ME 2001 Effects of estrogen on the vascular injury response in estrogen receptor α, β (double) knockout mice. Circ Res 89:534-539
67. Bakir S, Mori T, Durand J, Chen YF, Thompson JA, Oparil S 2000 Estrogen-induced vasoprotection is estrogen receptor dependent: evidence from the balloon-injured rat carotid artery model. Circulation 101:2342-2344
68. Hodgin JB, Krege JH, Reddick RL, Korach KS, Smithies O, Maeda N 2001 Estrogen receptor α is a major mediator of 17β-estradiol's atheroprotective effects on lesion size in apoE-/- mice. J Clin Invest 107:333-340
69. Gisclard V, Miller VM, Vanhoutte PM 1988 Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 244:19-22
70. Kauser K, Rubanyi GM 1994 Gender difference in bioassayable endothelium-derived nitric oxide from isolated rat aortae. Am J Physiol 267:H2311-H2317
71. Rubanyi GM, Freay AD, Kauser K, Sukovich D, Burton G, Lubahn DB, Couse JF, Curtis SW, Korach KS 1997 Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. Gender difference and effect of estrogen receptor gene disruption. J Clin Invest 99:2429-2437
72. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S 1994 Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 91:5212-5216
73. Bates TE, Loesch A, Burnstock G, Clark JB 1996 Mitochondrial nitric oxide synthase: a ubiquitous regulator of oxidative phosphorylation? Biochem Biophys Res Commun 218:40-44
74. Veille JC, Li P, Eisenach JC, Massmann AG, Figueroa JP 1996 Effects of estrogen on nitric oxide biosynthesis and vasorelaxant activity in sheep uterine and renal arteries in vitro. Am J Obstet Gynecol 174:1043-1049
75. Vagnoni KE, Shaw CE, Phernetton TM, Meglin BM, Bird IM, Magness RR 1998 Endothelial vasodilator production by uterine and systemic arteries. III. Ovarian and estrogen effects on NO synthase. Am J Physiol 275:H1845-H1856
76. Salhab WA, Shaul PW, Cox BE, Rosenfeld CR 2000 Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure. Am J Physiol 278:H2134-H2142
77. McNeill AM, Kim N, Duckles SP, Krause DN, Kontos HA 1999 Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke 30:2186-2190
78. Geary GG, McNeill AM, Ospina JA, Krause DN, Korach KS, Duckles SP 2001 Genome and hormones: gender differences in physiology. Selected contribution: cerebrovascular NOS and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-α. J Appl Physiol 91:2391-2399
79. Bell DR, Rensberger HJ, Koritnik DR, Koshy A 1995 Estrogen pretreatment directly potentiates endothelium-dependent vasorelaxation of porcine coronary arteries. Am J Physiol 268:H377-H383
80. Zoma WD, Baker RS, Clark KE 2000 Coronary and uterine vascular responses to raloxifene in the sheep. Am J Obstet Gynecol 182:521-528
81. Pavo I, Laszlo F, Morschl E, Nemcsik J, Berko A, Cox DA, Laszlo FA 2000 Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats. Eur J Pharmacol 410:101-104
82. Altavilla D, Saitta A, Galeano M, Squadrito G, Marino D, Minutoli L, Calapai G, Deodato B, D'Anna R, Corrado F, Caputi AP, Squadrito F 2001 The phytoestrogen α-zearalenol reverses endothelial dysfunction induced by oophorectomy in rats. Lab Invest 81:125-132
83. Squadrito F, Altavilla D, Squadrito G, Saitta A, Cucinotta D, Minutoli L, Deodato B, Ferlito M, Campo GM, Bova A, Caputi AP 2000 Genistein supplementation and estrogen replacement therapy improve endothelial dysfunction induced by ovariectomy in rats. Cardiovasc Res 45:454-462
84. Collins P, Shay J, Jiang C, Moss J 1994 Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation after acute estrogen withdrawal. Circulation 90:1964-1968
85. Ma XL, Gao F, Yao CL, Chen J, Lopez BL, Christopher TA, Disa J, Gu JL, Ohlstein EH, Yue TL 2000 Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat. J Pharmacol Exp Ther 295:786-792
86. Selles J, Polini N, Alvarez C, Massheimer V 2001 Progesterone and 17β-estradiol acutely stimulate nitric oxide synthase activity in rat aorta and inhibit platelet aggregation. Life Sci 69:815-827
87. Sudhir K, Chou TM, Mullen WL, Hausmann D, Collins P, Yock PG, Chatterjee K 1995 Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary, conductance and resistance arteries. J Am Coll Cardiol 26:807-814
88. Figtree GA, Lu Y, Webb CM, Collins P 1999 Raloxifene acutely relaxes rabbit coronary arteries in vitro by an estrogen receptor-dependent and nitric oxide-dependent mechanism. Circulation 100:1095-1101
89. Shaw L, Taggart MJ, Austin C 2000 Mechanisms of 17β-oestradiol induced vasodilatation in isolated pressurized rat small arteries. Br J Pharmacol 129:555-565
90. Karamsetty MR, Klinger JR, Hill NS 2001 Phytoestrogens restore nitric oxide-mediated relaxation in isolated pulmonary arteries from chronically hypoxic rats. J Pharmacol Exp Ther 297:968-974
91. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T 1995 Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 360:291-293
92. Hayashi T, Yamada K, Esaki T, Kuzuya M, Satake S, Ishikawa T, Hidaka H, Iguchi A 1995 Estrogen increases endothelial nitric oxide by a receptor-mediated system. Biochem Biophys Res Commun 214:847-855
93. MacRitchie AN, Jun SS, Chen Z, German Z, Yuhanna IS, Sherman TS, Shaul PW 1997 Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery, endothelium. Circ Res 81:355-362
94. Armour KE, Ralston SH 1998 Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells. Endocrinology 139:799-802
95. Nuedling S, Kahlert S, Loebbert K, Doevendans PA, Meyer R, Vetter H, Grohe C 1999 17β-Estradiol stimulates expression of endothelial and inducible NO synthase in rat myocardium in-vitro and in-vivo. Cardiovasc Res 43:666-674
96. Grande M, Carlstrom K, Stege R, Pousette A, Faxen M 2000 Estrogens increase the endothelial nitric oxide synthase (ecNOS) mRNA level in LNCaP human prostate carcinoma cells. Prostate 45:232-237
97. Kleinert H, Wallerath T, Euchenhofer C, Ihrig-Biedert I, Li H, Forstermann U 1998 Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 31:582-588
98. Nuedling S, Karas RH, Mendelsohn ME, Katzenellenbogen JA, Katzenellenbogen BS, Meyer R, Vetter H, Grohe C 2001 Activation of estrogen receptor β is a prerequisite for estrogen-dependent upregulation of nitric oxide synthases in neonatal rat cardiac myocytes. FEBS Lett 502:103-108
99. Sumi D, Hayashi T, Jayachandran M, Iguchi A 2001 Estrogen prevents destabilization of endothelial nitric oxide synthase mRNA induced by tumor necrosis factor α through estrogen receptor mediated system. Life Sci 69:1651-1660
100. Shaul PW 2002 Regulation of endothelial nitric oxide synthase: location, location, location. Annu Rev Physiol 64:749-774
101. Pelligrino DA, Ye S, Tan F, Santizo RA, Feinstein DL, Wang Q 2000 Nitric-oxide-dependent pial arteriolar dilation in the female rat: effects of chronic estrogen depletion and repletion. Biochem Biophys Res Commun 269:165-171
102. Xu HL, Galea E, Santizo RA, Baughman VL, Pelligrino DA 2001 The key role of caveolin-1 in estrogen-mediated regulation of endothelial nitric oxide synthase function in cerebral arterioles in vivo. J Cereb Blood Flow Metab 21:907-913
103. Jayachandran M, Hayashi T, Sumi D, Iguchi A, Miller VM 2001 Temporal effects of 17β-estradiol on caveolin-1 mRNA and protein in bovine aortic endothelial cells. Am J Physiol 281:H1327-H1333
104. Wagner AH, Schroeter MR, Hecker M 2001 17β-Estradiol inhibition of NADPH oxidase expression in human endothelial cells. FASEB J 15:2121-2130
105. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW 1997 Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 273:L119-L126
106. 2+ mobilization. Circ Res 81:885-892
107. Chen Z, Yuhanna IS, Galcheva-Gargova Z, Karas RH, Mendelsohn ME, Shaul PW 1999 Estrogen receptor α mediates the non-genomic activation of endothelial nitric oxide synthase by estrogen. J Clin Invest 103:401-406
108. Simoncini T, Genazzani AR 2000 Raloxifene acutely stimulates nitric oxide release from human endothelial cells via an activation of endothelial nitric oxide synthase. J Clin Endocrinol Metab 85:2966-2969
109. Kirsch EA, Yuhanna IS, Chen Z, German Z, Sherman TS, Shaul PW 1999 Estrogen acutely stimulates endothelial nitric oxide synthase in H441 human airway epithelial cells. Am J Respir Cell Mol Biol 20:658-666
110. Haynes MP, Sinha D, Russell KS, Collinge M, Fulton D, Morales-Ruiz M, Sessa WC, Bender JR 2000 Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells Circ Res 87:677-682
111. Simoncini T, Hafezi-Moghadam A, Brazil DP, Ley K, Chin WW, Liao JK 2000 Interaction of oestrogen receptor with the regulatory subunit of phosphatidylinositol-3-OH kinase. Nature 407:538-541
112. Hisamoto K, Ohmichi M, Kurachi H, Hayakawa J, Kanda Y, Nishio Y, Adachi K, Tasaka K, Miyoshi E, Fujiwara N, Taniguchi N, Murata Y 2001 Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells. J Biol Chem 276:3459-3467
113. Hisamoto K, Ohmichi M, Kanda Y, Adachi K, Nishio Y, Hayakawa J, Mabuchi S, Takahashi K, Tasaka K, Miyamoto Y, Taniguchi N, Murata Y 2001 Induction of endothelial nitric-oxide synthase phosphorylation by the raloxifene analog LY117018 is differentially mediated by Akt and extracellular signal-regulated protein kinase in vascular endothelial cells. J Biol Chem 276:47642-47649
114. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, Golan DE 1999 Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 96:2788-2793
115. Stefano GB, Prevot V, Beauvillain JC, Cadet P, Fimiani C, Welters I, Fricchione GL, Breton C, Lassalle P, Salzet M, Bilfinger TV 2000 Cell-surface estrogen receptors mediate calcium-dependent nitric oxide release in human endothelia. Circulation 101:1594-1597
116. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR 2000 Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. J Biol Chem 275:5026-5030
117. Watson CS, Gametchu B 1999 Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 220:9-19
118. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR 2000 Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97:5930-5935
119. Razandi M, Pedram A, Greene GL, Levin ER 1999 Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERα and ERβ expressed in Chinese hamster ovary cells. Mol Endocrinol 13:307-319
120. Shaul PW, Smart EJ, Robinson LJ, German Z, Yuhanna IS, Ying Y, Anderson RG, Michel T 1996 Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J Biol Chem 271:6518-6522
121. Garcia-Cardena G, Oh P, Liu J, Schnitzer JE, Sessa WC 1996 Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc Natl Acad Sci USA 93:6448-6453
122. Shaul PW, Anderson RGW 1998 Role of plasmalemmal caveolae in signal transduction. Am J Physiol 275:L843-L851
123. Chambliss KL, Yuhanna IS, Mineo C, Liu P, German Z, Sherman TS, Mendelsohn ME, Anderson RG, Shaul PW 2000 Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ Res 87:E44 -E52
124. Chambliss KL, Yuhanna IS, Anderson RG, Mendelsohn ME, Shaul PW 2002 Estrogen receptor β has nongenomic action in caveolae. Mol Endocrinol 16:938-946
125. Liu J, Conklin BR, Blin N, Yun J, Wess J 1995 Identification of a receptor/G-protein contact site critical for signaling specificity and G-protein activation. Proc Natl Acad Sci USA 92:11642-11646
126. Vanhoutte PM 1997 Endothelial dysfunction and atherosclerosis. Eur Heart J 18(Suppl):E19-E29
127. Wess J 1998 Molecular basis of receptor/G-protein-coupling selectivity. Pharmacol Ther 80:231-264
128. Gilman AG 1995 Nobel Lecture. G proteins and regulation of adenylyl cyclase. Biosci Rep 15:65-97
129. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW 2001 Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gα(i). J Biol Chem 276:27071-27076
130. Carry DJ 1994 Pertussis toxin-catalyzed ADP-ribosylation of G proteins. Methods Enzymol 237:63-70
131. Neer EJ 1995 Heterotrimeric G proteins: organizers of transmembrane signals. Cell 80:249-257
132. Morris AJ, Malbon CC 1999 Physiological regulation of G protein-linked signaling. Physiol Rev 79:1373-1430
133. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB 2000 Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors. Nature 403:274-280
134. Huang C, Hepler JR, Gilman AG, Mumby SM 1997 Attenuation of Gi- and Gq-mediated signaling by expression of RGS4 or GAIP in mammalian cells. Proc Natl Acad Sci USA 94:6159-6163
135. LeMellay V, Grosse B, Lieberherr M 1997 Phospholipase Cβ and membrane action of calcitriol and estradiol. J Biol Chem 272:11902-11907
136. Benten WP, Stephan C, Lieberherr M, Wunderlich F 2001 Estradiol signaling via sequestrable surface receptors. Endocrinology 142:1669-1677
137. 125I-BSA] binding sites in the medial preoptic area and anterior hypothalamus. Brain Res 693:225-232
138. Chen YZ, Qiu J 1999 Pleiotropic signaling pathways in rapid, nongenomic action of glucocorticoid. Mol Cell Biol Res Commun 2:145-149
139. 3 stimulation of phospholipases C and D in muscle cells involves extracellular calcium and a pertussis-sensitive G protein. Mol Cell Endocrinol 122:207-211
140. Benten WP, Lieberherr M, Stamm O, Wrehlke C, Guo Z, Wunderlich F 1999 Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages. Mol Biol Cell 10:3113-3123
141. Jun SS, Chen Z, Pace MC, Shaul PW 1998 Estrogen upregulates cyclooxygenase-1 gene expression in ovine fetal pulmonary artery endothelium. J Clin Invest 102:176-183